Eliem Therapeutics, Inc.
USD5.11
-0.05 (-0.97%)
CEO
Aoife M. Brennan BAO, BCh, MB, MMSc
IPO Date
2021-08-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.12
Prev. Close
$5.16
Day Low
$5.00
Day High
$5.26
52W Low
$2.35
52W High
$11.55
Market Cap
$0.34B
Volume
0.80M
| 77,500 |
| $0.00 |
| 26 Aug 2024 | Kaplan Brett | — | Disposed | 0 | $0.00 |
| 1 Jul 2024 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 11,949,171 | $3.84 |
| 1 Jul 2024 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | A-Award | Acquired | 973,000 | $0.00 |
| 1 Jul 2024 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 1,059,375 | $3.84 |
| 1 Jul 2024 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | A-Award | Acquired | 2,479,872 | $0.00 |
| 1 Jul 2024 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | A-Award | Acquired | 1,807,000 | $0.00 |
| 28 Jun 2024 | Ratcliffe Liam | director | A-Award | Acquired | 10,000 | $7.89 |
| 28 Jun 2024 | Dunn Judith | director | A-Award | Acquired | 10,000 | $7.89 |